In a 56-day phase-2 trial, 9 participants with severe dry eye syndrome were treated with synthetic TB4 eye drops or placebo for 28 days, followed by a 28-day observational period
These findings are from cell studies and haven't been confirmed in a large human clinical trial, but the mechanistic logic is consistent
therefore, the concentration was too low for XRPD
Anti-Inflammatory Properties: GHK-Cu helps to reduce inflammation and soothe irritated tissues, which is beneficial in healing skin conditions and injuries
Thats why experienced clinicians dont begin by asking, Which peptide should we use? They begin by asking, What are we treating? That distinction influences every decision that follows, including whether peptide therapy is appropriate at all
Rotating sites helps prevent lipodystrophy and injection site reactions